Industry | 2009.08.26
National Quality Forum Endorses IMS Health Measures to Improve Medication Safety and Quality
NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, has received the endorsement of the National Quality Forum (NQF) for two of its clinical quality indicators for measuring medication usage and patient adherence. The IMS measures address the use of antipsychotics by patients with schizophrenia, and medications used by patients with coronary artery disease. Consensus standards endorsed
For more information, please visit
http://www.businesswire.com/news/home/20090826005563/en
